Corinna Eschbach

A Randomized Phase II Study of Pemetrexed in Combination With Cisplatin or Carboplatin as First-Line Therapy for Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer

Wolfgang Schuette, A Gröschel, Martin Sebastian et al. · Clinical Lung Cancer · 2013 · 46 citations

Medicine, Oncology, Pharmacology +13

Randomized, Double-Blind, Phase II Trial Comparing Gemcitabine-Cisplatin plus the LTB4 Antagonist LY293111 versus Gemcitabine-Cisplatin plus Placebo in First-Line Non–Small-Cell Lung Cancer

Pasi A. Jänne, Luis Paz‐Ares, Yun Oh et al. · Journal of Thoracic Oncology · 2013 · 34 citations

Medicine, Oncology, Pharmacology +13

The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer

Akin Atmaca, Salah‐Eddin Al‐Batran, Ralph M. Wirtz et al. · International Journal of Cancer · 2013 · 33 citations · Full text

Medicine, Molecular Biology, Oncology +17

Severe symptoms and very low quality-of-life among outpatients newly diagnosed with advanced cancer: data from a multicenter cohort study

Waldemar Siemens, Stefan S. Schönsteiner, Claudia L. Orellana‐Rios et al. · Supportive Care in Cancer · 2020 · 24 citations · Full text

Medicine, Oncology, Cancer Symptom Management +12

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Johan Vansteenkiste, Rodryg Ramlau, Joachim von Pawel et al. · Oncology · 2012 · 18 citations

Medicine, Oncology, Pharmacology +13